Friday, July 31, 2015 Last update: 1:33 AM - Covering Large & Obscure Tech Companies Since 1996

Biomedical / Biotech / Health News

Thursday, July 30, 2015

  • Posted at 4:00 AM
    NeuWave Medical® Inc., a privately held medical device company focused on developing disruptive technology for use in the ablation of soft-tissue lesions has received FDA clearance for its new Ablation Confirmation™ (AC) software integrated into the NeuWave Intelligent Ablation System. The totality of the NeuWave System ... read more
  • Posted at 4:00 AM
  • Posted at 4:00 AM
    SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 07/30/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today reported financial results for the second quarter 2015. Revenue for the second quarter ended June 30, 2015 was $3.7 million. The operating loss for the second quarter ended June 30, 2015 was $8.9 million. The net loss for the second quarter ended June 30, 2015 was $8.3 million, which included the operating loss of $8.9 million and non-cash income of $0.6 million related to ... read more
  • Posted at 4:00 AM
    EXTON, PA -- (Marketwired) -- 07/30/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter of 2015 and updated financial guidance for the full year 2015. Executive Summary Reported sales of $359.7 million declined 2.5% vs. 2014 period. Net sales at constant currency grew by 7.4%. Reported diluted EPS was $0.38. Adjusted diluted EPS was $0.47, excluding a $0.09 charge on executive retirement. EPS comparisons to the prior-year period are adversely impacted by approximately ... read more
  • Posted at 3:49 AM
    Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) (BSE: 500124) (NSE: DRREDDY) today announced its consolidated financial results for the quarter ended June 30, 2015 under International Financial Reporting Standards (IFRS). Q1 FY16: Key Highlights ... read more
  • Posted at 3:30 AM
    Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the second quarter of 2015. Net product sales of Soliris® (eculizumab) grew to $636 million, a 24% increase, compared to $512.5 million for the same period in 2014, despite currency headwinds. Non-GAAP diluted earnings per share (EPS) ... read more
  • Posted at 3:30 AM
    Sevion Therapeutics, Inc. (“Sevion” or the “Company”) (OTCQB: SVON), a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, has entered into an agreement with Malvern Instruments establishing a new biopharmaceutical applications laboratory in the ... read more
  • Posted at 3:10 AM is pleased to offer users access to two of Packaged Facts' most recent reports covering marketing trends in technology, mobile, and social media for the foodservice and retail food industries in the U.S. The food retailing and foodservice industries are experiencing major changes because of technology, mobile, and social media. These all are contributing to the way consumers interact with restaurants and grocery stores. To learn more, check out the two reports: -- Retail Food Marketing Trends ... read more
  • Posted at 3:01 AM
    Acorda Therapeutics, Inc. (Nasdaq:ACOR) today provided a financial and pipeline update for the second quarter ended June 30, 2015. “The growth of AMPYRA over the last several quarters is a result of our team’s continued strong performance in educating ... read more
  • Posted at 3:00 AM
    HOUSTON, TX -- (Marketwired) -- 07/30/15 -- Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) ("Nobilis" or the "Company") today announced that the U.S. Bankruptcy Court for the Northern District of Texas, approved a Sale Order for the sale of assets of Victory Plano Hospital, LP ("Plano") for a total purchase price of approximately $5.8 million. The purchase price consisted of a cash payment of $1.3 million, the assumption of Plano's loan with Legacy Bank of approximately $4.5 million ... read more

Wednesday, July 29, 2015

  • Posted at 11:10 PM
    Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has submitted the cobas® EGFR Mutation Test v2 for Premarket Approval (PMA) to the U.S. Food and Drug Administration (FDA), as a companion diagnostic test for AZD9291, an AstraZeneca investigational therapy for non-small cell lung cancer patients with an acquired resistant mutation. Patients with non-small cell lung cancer who have adenocarcinoma with tumor containing an EGFR sensitizing mutation show significant benefit from currently available EGFR TKI therapies. However, approximately two-thirds ... read more
  • Posted at 11:00 PM
    Novare Pharmaceuticals today announced that the U.S. Patent and Trademark Office issued patent #9,090,659, with claims covering the composition-of-matter and use of RHAMM-binding peptides with a wide range of potential therapeutic uses. The patent also has claims for the diagnosis and prognosis of cancer, and for ... read more
  • Posted at 11:00 PM
    Genkyotex, the leading developer of selective NOX inhibitors, announced today publication of results from two independent studies confirming the important role played by both NOX1 and NOX4 enzymes in the development of liver fibrosis. This research, conducted at University of California, San Diego, and University of ... read more
  • Posted at 10:19 PM
    Astellas today announced topline results from the Phase 3 ACTIVE study evaluating the efficacy and safety of intravenous (IV) and oral isavuconazole, commercially known as CRESEMBA® (isavuconazonium sulfate), under development for adults with candidemia and other invasive Candida infections. Results from the study demonstrated that the trial did not meet its primary endpoint of non-inferiority in overall treatment response in isavuconazole-treated patients at the end of IV therapy compared to caspofungin. The key secondary endpoint of IV isavuconazole followed by ... read more
  • Posted at 6:47 PM
    vTv Therapeutics Inc. (the “Company”) (Nasdaq:VTVT) announced today the pricing of its initial public offering of 7,812,500 shares of its Class A common stock at a price to the public of $15.00 per share. All of the shares are being offered by the Company. In addition, the Company has ... read more
  • Posted at 5:49 PM
    High performance web hosting provider A2 Hosting first made a name for themselves back in 2004 by being one of the first hosts to support PHP 5. With the recent Beta release of PHP 7, history repeats itself with A2 Hosting being one of the first providers to offer PHP 7 Hosting. PHP 7 is available on A2 Hosting's Turbo Web Hosting service. Speed tests show A2 Hosting's Turbo Servers load pages up to 20X faster than competing services. Unlike other ... read more
  • Posted at 4:51 PM
    Experian Marketing Services, a recognized leader in cloud-based marketing technology, data and service, today announced it was named a Strong Performer in the Forrester Research, Inc. July 2015 report The Forrester Wave((TM)): Real Time Interaction Management, Q3 2015. The report evaluated 11 vendors based on 35 criteria points. Forrester Research stated in the report that Experian Marketing Services "enters the market with a promising platform. Nearly half of its customers are retailers that execute dynamic email, but the majority also deploy ... read more
  • Posted at 4:49 PM
    C Spire Business Solutions has developed an enterprise sales team focused solely on cloud-based services optimized to provide the superior uptime, compliance and security demanded by vital service organizations such as hospitals, banks and government agencies. C Spire's award-winning IT team, dedicated sales consultants and unrivaled local support deliver a deep service relationship, uninterrupted service and secure performance. Opened in November 2014, C Spire's data center is the only Tier III+ data facility within 250 miles of its Starkville, MS location ... read more
  • Posted at 4:29 PM
    Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod(®) Insulin Management System, today announced preliminary revenue results for the three months ended June 30, 2015. The Company also announced that it will postpone the full release of its second quarter financial results and conference call from Thursday, July 30, as originally scheduled. Preliminary Second Quarter Revenue Highlights: -- Preliminary second quarter revenue results: -- ... read more
  • Posted at 4:11 PM
    iBiz Software Inc., a Platinum level member of Oracle® Partner Network (OPN), announced today that it has achieved Oracle Validated Integration of TaxIntegra version 1.1 with Oracle commerce v11.1. With TaxIntegra, users can integrate Oracle Web Commerce with popular tax engines such as Avalara, Vertex, Taxware and other open tax solutions using a proprietary dashboard UI where users can change their tax engine based on their business requirements. Logo - To achieve Oracle Validated Integration, Oracle partners are required to ... read more